Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Northwest Bancshares | NWBI | 2. avr 2025 | 12.17 | +1.00 |
Northwest Natural Holdings | NWN | 2. avr 2025 | 43.16 | +0.35 |
Northwest Pipe | NWPX | 2. avr 2025 | 42.87 | +2.71 |
NorthWestern Energy | NWE | 2. avr 2025 | 58.90 | +0.67 |
Norwegian Cruise Line | NCLH | 2. avr 2025 | 19.50 | +2.31 |
Norwood Financial | NWFL | 2. avr 2025 | 24.32 | -0.98 |
Nouveau Monde Graphite | NMG | 2. avr 2025 | 1.50 | -1.32 |
NOV | NOV | 2. avr 2025 | 15.30 | -0.71 |
Nova | NVMI | 2. avr 2025 | 191.68 | +3.67 |
Nova Lifestyle | NVFY | 2. avr 2025 | 0.65 | -3.26 |
Nova Minerals | NVA | 2. avr 2025 | 10.95 | -1.88 |
Novabay Pharmaceuticals | NBY | 2. avr 2025 | 0.57 | -2.24 |
Novagold Resources | NG | 2. avr 2025 | 2.92 | -2.01 |
Novanta | NOVT | 2. avr 2025 | 128.65 | +0.90 |
Novartis ADR | NVS | 2. avr 2025 | 110.77 | +1.06 |
Novavax | NVAX | 2. avr 2025 | 5.98 | -0.33 |
Novo Nordisk ADR | NVO | 2. avr 2025 | 68.24 | +0.31 |
NovoCure | NVCR | 2. avr 2025 | 17.94 | +2.40 |
Novonix ADR | NVX | 2. avr 2025 | 1.11 | +0.91 |
NPK International | NPKI | 2. avr 2025 | 6.20 | +3.16 |
NRG Energy | NRG | 2. avr 2025 | 102.88 | +4.41 |
NRx Pharmaceuticals | NRXP | 2. avr 2025 | 2.01 | +3.61 |
NSTS Bancorp | NSTS | 2. avr 2025 | 11.12 | -2.63 |
Nu Holdings | NU | 2. avr 2025 | 10.59 | +1.53 |
Nu Skin Enterprises | NUS | 2. avr 2025 | 7.13 | -1.25 |
Nuburu | BURU | 2. avr 2025 | 0.17 | -2.18 |
NuCana ADR | NCNA | 2. avr 2025 | 0.90 | +1.13 |
Nucor | NUE | 2. avr 2025 | 123.03 | +2.82 |
Nukkleus | NUKK | 2. avr 2025 | 13.89 | +9.11 |
Nurix Therapeutics | NRIX | 2. avr 2025 | 11.38 | +8.69 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.